http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2018002136-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93cd4ab6c0b119843367e0df0ecda6c0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
filingDate 2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc769df93f7e199cd2931d8fc9e82612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ae108781b6a5a1c6d03852cca15b2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba87cc1073e8ab72fa7429b27ba9c7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e02a701dd476dabe18cd366646c4e380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f3bc755ff8c3bee886273299634c9dc
publicationDate 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2018002136-A1
titleOfInvention Combinations of histamine dihydrochloride and use of these
abstract THE PRESENT INVENTION PROVIDES METHODS FOR TREATING CANCER IN A SUBJECT, AVOIDING OR DELAYING THE RECOVERY OF A CANCER IN A SUBJECT IN REMISSION, PROLONGING THE REMISSION OF CANCER, INCREASING SURVIVAL, AND DECREASING TO DELIVER THE ADMINISTRATION OF HISTAMINE DIHYCHROCHLORIDE AND AN INHIBITOR OF PROTEIN 1 OF THE PROGRAMMED CELL DEATH (PD-1) OR OF THE BINDING 1 OF THE PROGRAMMED CELL DEATH (PD-L1) OB) OPTIONALLY ADMINISTER AN AGENT THAT DECREASES THE REAGGING SPECIES OF (OX) , TOGETHER WITH A HISTAMINE RECEIVER AGONIST. THE PRESENT INVENTION PROVIDES, IN ADDITION, METHODS FOR PREACHING THE EFFECTIVENESS OF A TREATMENT AGAINST CANCER BASED ON A REDISTRIBUTION OF CYTOTOXIC T-CELLS, FREQUENCY OF NK CELLS, OR OTHER BIOCHEMICAL CHANGES TO AND PROVIDED FOR THE EVOLUTION THE REMISSION OF A CANCER. IN ADDITION, RELATED KITS AND COMPOSITIONS ARE PROVIDED.
priorityDate 2016-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192901

Total number of triples: 33.